Evandro de Azambuja - Publications, H-index & Citations

Evandro de Azambuja

institut jules bordet and l'universite libre de bruxelles

85H指数

725论文数

3.8W被引数

收录论文 319

发表时间

From Site-Centered to Patient-Centered: Promises and Challenges of Decentralized Clinical Trials in Oncology 从以研究地点为中心到以患者为中心：肿瘤学去中心化临床试验的机遇与挑战

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2026-08-22

PREAI

Gabriella Gentile; Elisa Agostinetto; Luca Arecco; Riccardo Gerosa; Roberto Buonaiuto; Soraia Lobo-Martins; Matteo Lambertini; Andrea Botticelli; Martine Piccart-Gebhart; Evandro de Azambuja

EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study 内分泌治疗联合CDK4/6抑制剂后进展的ER阳性/HER2阴性晚期乳腺癌中依维莫司的有效性：EVERGREEN研究

Breast Cancer Research and Treatment

IF3

2026-07-10

PREAI

Diogo Martins-Branco; Soraia Lobo-Martins; Philippe Aftimos; Bernardo Pereira; Leonor Vasconcelos de Matos; Leonor Fernandes; Elsa Campôa; Guilherme Nader-Marta; Michel Moreau; Donatienne Taylor; Francois P. Duhoux; Pedro Simões; Ana Rita Garcia; Vanessa Patel; Caterina Confente; Diogo Alpuim Costa; José Pereira; Catarina Santos; Marianne Paesmans; Frederico Sarmento; Teresa Gantes Padrão; Diana Simão; Daniel Bandarra; Berta Sousa; Margarida Brito; Andrea Gombos; Lieveke Ameye; Evandro de Azambuja

Body Mass Index in Postmenopausal Women with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer: An Exploratory Analysis of the LORELEI trial.雌激素受体阳性、HER2阴性早期乳腺癌绝经后女性中的体重指数：LORELEI试验的探索性分析

European Journal of Cancer

IF7.1

2026-06-12

PREAI

Chiara Dauccia; Maria Alice Franzoi; Cristina Saura; Dominik Hlauschek; Lidija Sölkner; Michael Gnant; Peter C. Dubsky; Ruth Helfgott; Gabriele Zoppoli; Mafalda Oliveira; Laetitia Collet; Jill Fredrickson; Timothy R. Wilson; Luca Arecco; Elisa Agostinetto; Evandro de Azambuja

Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia 萨卡图zumab govitecan在转移性乳腺癌患者中的应用：来自北美、欧洲和亚洲患者数据的合并安全性分析

ESMO Open

IF8.3

2026-03-19

OAAI

H.S. Rugo; S.M. Tolaney; J. Cortés; F. Marmé; E. de Azambuja; B. Xu; J. Sohn; Y. Naito; T. Valdez; D. Gary; J. Zhu; C. Lai; A. Bardia

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer

New England Journal of Medicine

IF78.5

2026-01-22

PREAI

Tolaney, Sara M.; de Azambuja, Evandro; Kalinsky, Kevin; Loi, Sherene; Kim, Sung-Bae; Yam, Clinton; Rapoport, Bernardo; Im, Seock-Ah; Pistilli, Barbara; Mchayleh, Wassim; Cescon, David W.; Watanabe, Junichiro; Banuelas, Manuel Alejandro Lara; Freitas-Junior, Ruffo; Salvador Bofill, Javier; Afshari, Maryam; Gary, Dianna; Wang, Lu; Lai, Catherine; Schmid, Peter

HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trial

The Breast

IF0

2026-01-21

OAAI

Christian F. Singer; Franz Koenig; Stephanie Kacerovsky-Strobl; Sabine Danzinger; Christine Brunner; Christoph Suppan; Christine Deutschmann; Marija Balic; Richard Greil; Daniel Egle; Evandro de Azambuja; Serena Di Cosimo; Anup Choudhury; Michael Gnant

20th anniversary of adjuvant trastuzumab: reflections on a breakthrough moment 佐剂曲妥珠单抗20周年: 突破时刻的反思

Annals of Oncology

IF65.4

2025-12-11

PREAI

G. Gentile; R. Gerosa; E. de Azambuja; M. Piccart-Gebhart

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors ESMO-ESTRO关于将放射治疗与CDK4/6、HER2、PARP或mTOR抑制剂联合应用的安全性共识声明

Radiotherapy and Oncology

IF5.3

2025-12-11

OAAI

Evert S.M. van Aken; Ajeet Kumar Gandhi; Sean M. O’Cathail; Gerben Borst; Jorge Barriuso; Emmanouil Fokas; Luis Castelo-Branco; Anne Hansen Ree; Evandro de Azambuja; Stephanie Kroeze; Ilaria Colombo; Antonin Levy; Carmen Criscitiello; Maximilian Niyazi; Nadia Harbeck; Ewa Szutowicz; Gabor Liposits; Marcel Verheij; Isabelle Ray-Coquard; Paolo Tarantino

RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer RSC4All 作为一种机器学习列线图，用于预测 HR+/HER2- 淋巴结阴性早期乳腺癌的 RSClin™ 结果

ESMO Open

IF8.3

2025-10-07

OAAI

F. Jacobs; S. D’Amico; E. Ferraro; E. Agostinetto; C. Tondini; M. Gaudio; C. Benvenuti; R. Gerosa; G. Saltalamacchia; E. Zazzetti; R. Di Rienzo; R. Buonaiuto; F. Martorana; A. Chirco; R. De Sanctis; M.G. Della Porta; A. Santoro; P. Vigneri; M.G. Arpino; M. Giuliano; M. Fornier; E. de Azambuja; A. Zambelli

An Unforeseen, Existential Threat to Oncological Research in Europe 一个突如其来的、对欧洲肿瘤学研究构成生存威胁的因素

Annals of Oncology

IF65.4

2025-09-26

PREAI

J-Y. Blay; A. Cervantes; F. André; S. Peters; N. Harbeck; E. Azambuja; G. Curigliano

Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge 管理辅助CDK4/6抑制剂治疗期间或治疗后在HR阳性/HER2阴性早期乳腺癌中的复发：一个新兴的挑战

ESMO Open

IF8.3

2025-09-06

OAAI

R. Gerosa; G. Gentile; L. Arecco; C. Dauccia; S. Nannini; S. Lobo-Martins; E. Agostinetto; M. Lambertini; A. Santoro; P. Aftimos; M. Piccart-Gebhart; E. de Azambuja

Characteristics, Treatment Patterns and Clinical Outcomes of Women with Maghreb Origin and Diagnosis of Breast Cancer: A Single-Center, Retrospective Cohort Study 特征、治疗模式及临床结局：具有马格里伯血统并被诊断为乳腺癌的女性——一项单中心、回顾性队列研究

Clinical Breast Cancer

IF2.5

2025-06-27

PREAI

Chiara Dauccia; Diogo Martins-Branco; Michel Moreau; Lieveke Ameye; Elisa Agostinetto; Luca Arecco; Soraia Lobo-Martins; Anja Skoporc; Isabel Vilas-Boas; Masa Auprih; Ahmad Awada; Véronique Debien; Evandro de Azambuja

Long-term Reproductive and Oncological Outcomes of Patients with Breast Cancer : Final analysis of the Brovale trial 乳腺癌患者的长期生殖和肿瘤学结局：Brovale试验的最终分析

HUMAN REPRODUCTION

IF6.1

2025-06-01

OAAI

Rabattu, A.; Lambertini, M.; Houba, C.; Findikli, N.; De Azambuja, E.; Arreco, L.; Delbaere, A.; Demeestere, I; Goldrat, O.

Cardiovascular toxicity of breast cancer treatments: from understanding to enhancing survivorship care 乳腺癌治疗的心血管毒性：从理解到提升幸存者护理

ESMO Open

IF8.3

2025-06-01

OAAI

C. Dauccia; E. Agostinetto; L. Arecco; S. Lobo-Martins; M. Gitto; A.R. Lyon; T. López-Fernández; S. Dent; G. Casalino; V. Agarwala; E. de Azambuja

Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy 新辅助全身治疗后保乳手术后 margin distance 对复发和生存的影响

NPJ BREAST CANCER

IF7.6

2025-05-19

OAAI

Pop, C. Florin; Ortega, Clemence; Lecomte, Mathilde; Kristanto, Paulus; Khaled, Chirine; De Neubourg, Filip; Desmet, Antoine; De Azambuja, Evandro; Larsimont, Denis; Veys, Isabelle

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study 真实世界中接受辅助紫杉醇联合曲妥珠单抗（APT）方案治疗的I期HER2阳性早期乳腺癌患者的5年结果：一项国际回顾性研究

Clinical Breast Cancer

IF2.5

2025-05-15

PREAI

Soraia Lobo-Martins; Veronique Debien; Elisa Agostinetto; Marianna Sirico; Giselle de Souza Carvalho; Flavia Jacobs; Chiara Molinelli; Renata Colombo Bonadio; Pedro Bergmann; Cristiano de Pádua Souza; Laura Testa; Marina Nishimuni; André João Rossi; Gabriel Kamei Guimarães; Michel Moreau; Ugo De Giorgi; José Bines; Armando Santoro; Donatienne Taylor; Francois P. Duhoux; Giacomo Barchiesi; Matteo Lambertini; Martine Piccart; Evandro de Azambuja

Response to Venkataraman and Mokbel 对Venkataraman和Mokbel的回应

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2025-05-08

PREAI

Arecco, Luca; Blondeaux, Eva; Agostinetto, Elisa; De Azambuja, Evandro; Lambertini, Matteo; Del Mastro, Lucia

Extended adjuvant endocrine therapy in early breast cancer: finding the individual balance 早期乳腺癌的延长辅助内分泌治疗：寻找个体化平衡

ESMO OPEN

IF8.3

2025-05-01

PREAI

Lobo-Martins, S.; Arecco, L.; Cabral, T. P.; Agostinetto, E.; Dauccia, C.; Franzoi, M. A.; del Mastro, L.; Lambertini, M.; Piccart, M.; de Azambuja, E.

Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial 在APHINITY试验中，他汀类药物使用与早期HER2阳性乳腺癌患者生存结局的关联

BREAST CANCER RESEARCH AND TREATMENT

IF3

2025-04-28

OAAI

Maurer, Christian; Agostinetto, Elisa; Ameye, Lieveke; Lambertini, Matteo; Martel, Samuel; Ponde, Noam; Brandao, Mariana; Poggio, Francesca; Ferreira, Arlindo; Schiff, Rachel; De Angelis, Carmine; Gelber, Richard D.; Dent, Susan; Thomssen, Christoph; Piccart, Martine; de Azambuja, Evandro

Cardiovascular Safety in Oncology Clinical Trials JACC: CardioOncology Primer 肿瘤学临床试验中的心血管安全性 JACC: CardioOncology Primer

JACC: CARDIOONCOLOGY

IF12.8

2025-02-01

OAAI

Bonaca, Marc P.; Lang, Ninian N.; Chen, Alice; Amiri-Kordestani, Laleh; Lipka, Leslie; Zwiewka, Michal; Strnadova, Colette; Klaar, Sigrid; Dent, Susan; Janicijevic, Tijana Krnjeta; Herrmann, Joerg; Barac, Ana; Boer, Rudolf A. de; Deswal, Anita; Schou, Morten; Neilan, Tomas G.; van der Meer, Peter; Moslehi, Javid; Kondapalli, Lavanya; Ky, Bonnie; Fernandez, Teresa Lopez; Cornell, R. Frank; Flaig, Thomas W.; Hsia, Judith; Sharon, Elad; de Azambuja, Evandro; Seltzer, Jonathan; Januzzi, James L.; Petrie, Mark C.

研究方向